Discover
DXR
Daxor Corporation
10.35
12 x 11.50
1 x 10.03
bid
ask
+
0.06
0.54%
7 @ 04:00 PM
10.33 -0.02 (0.19%)
| Ytd | -29.83% | |
| 1y | 7.25% |
10.35
day range
10.35
8.56
52 week range
14.76
| Open | 10.35 | Prev Close | 10.29 | Low | 10.35 | High | 10.35 | Mkt Cap | 60.43M |
| Vol | 1.24K | Avg Vol | 7.27K | EPS | 1.64 | P/E | 6.31 | Forward P/E | N/A |
| Beta | -0.54 | Short Ratio | 0.60 | Inst. Own | 1.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 01-05 | Earning | 03-06 | 50-d Avg | 10.31 | 200-d Avg | 11.82 | 1yr Est | 23.38 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2013-03-29 | 2012-12 | 0 | N/A | N/A | N/A |
| 2012-12-07 | 2012-09 | 0 | N/A | N/A | N/A |
| 2012-08-31 | 2012-06 | 0 | N/A | N/A | N/A |
| 2012-06-01 | 2012-03 | 0 | N/A | N/A | N/A |
| 2012-03-28 | 2011-12 | 0 | N/A | N/A | N/A |
| 2011-11-14 | 2011-09 | 0 | N/A | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-09-09 | Ascendiant Capital | Upgrade | Buy | Buy |
| 2019-07-29 | Maxim Group | Upgrade | Buy | |
| 2019-05-16 | Ascendiant Capital | Upgrade | Buy |
Profile
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-12-05 | FELDSCHUH JONATHAN ADAM | Officer and Director | 35.91K | Purchase |
| 2024-12-05 | FELDSCHUH MICHAEL RICHARD | Chief Executive Officer | 207.49K | Purchase |
| 2024-03-03 | FEUER EDWARD | Director | 1000 | Purchase |
| 2023-05-23 | GOUDIE JOY S | Director | 300.00 | Purchase |
| 2023-09-17 | JOSEPH FELDSCHUH UEO | Trustee | 2.55M | Stock Gift |
| 2024-03-26 | MICHEL ROBERT J | Chief Financial Officer | 11.30K | Purchase |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Group Inc | 48.83K | 405.27K | 1.01% |
| 2024-09-29 | Renaissance Technologies, LLC | 14.82K | 123.01K | 0.31% |
| 2024-09-29 | Keyes, Stange & Wooten Wealth Management, LLC | 14.61K | 121.28K | 0.30% |
| 2024-09-29 | Osaic Holdings Inc | 7.20K | 59.76K | 0.15% |
| 2024-09-29 | UBS Group AG | 1.24K | 10.26K | 0.03% |
| 2024-09-29 | Princeton Global Asset Management LLC | 500.00 | 4.15K | 0.01% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 48.83K | 405.27K | 1.01% |
| 2024-09-29 | Bridgeway Funds Inc-Ultra Small Company Market Fund | 6.31K | 52.33K | 0.13% |
| 2024-09-29 | Gabelli Global Mini Mites Fund | 400.00 | 3.32K | 0.01% |
| 2024-09-29 | Northern Small Cap Core Fund | 37.00 | 307.00 | 0.00% |
Dividend
| Dividend | Date |
|---|---|
| 0.03 | 2018-01-05 |
| 0.03 | 2017-12-20 |
| 0.03 | 2016-12-20 |
| 0.04 | 2015-12-18 |
| 0.03 | 2014-12-04 |
| 0.05 | 2013-12-05 |